Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment–induced sleep quality deterioration in patients with non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment–induced sleep quality deterioration in patients with non-muscle invasive bladder cancer

Published:2022-04-14 Issue:7 Volume:30 Page:6145-6153
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Miyake Makito^ORCID,Nishimura Nobutaka,Ohnishi Sayuri,Oda Yuki,Miyamoto Tatsuki,Shimizu Takuto,Hori Shunta,Morizawa Yosuke,Gotoh Daisuke,Nakai Yasushi,Anai Satoshi,Torimoto Kazumasa,Aoki Katsuya,Fujii Tomomi,Tanaka Nobumichi,Fujimoto Kiyohide

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07043-0.pdf

Reference29 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

2. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81:75–94

3. Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M et al (2020) Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: revision working position paper. Int J Urol 27:362–368

4. Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK et al (2020) Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18:329–354

5. Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD et al (2014) Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur Urol 66:1148–1156